For example, it has been observed that dioscin induced macrophage M2-to-M1 phenotype transition in vitro and inhibited IL-10 secretion, and it may act as a new anti-tumor agent by down-regulating STAT3 and JNK signaling pathways in macrophages in vitro [43]. The gene discussed is STAT3; the disease is neoplasm.